CoChat

Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study

Open access
Tanabe, Hayato, Saito, Haruka, Kudo, Akihiro, Machii, Noritaka, Hirai, Hiroyuki, Maimaituxun, Gulinu, Tanaka, Kenichi, Masuzaki, Hiroaki, Watanabe, Tsuyoshi, Asahi, Koichi, Kazama, Junichiro, Shimabukuro, Michio · 2020 · Journal of Clinical Medicine
Cited by 112

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Diabetes is a complex and heterogeneous disease, making the prediction of the risks of diabetic complications challenging. Novel adult-onset diabetes subgroups have been studied using cluster analysis, but its application in East Asians remains unclear. We conducted a retrospective cohort study to elucidate the clinical utility of cluster-based subgroup analysis in the Japanese population. Cluster analysis based on anti-glutamate decarboxylase antibody (GAD antibody) levels, age at diagnosis, body mass index (BMI), hemoglobin A1c (A1c), and homeostatic model assessment 2 estimates of β-cell function and insulin resistance was performed in 1520 diabetic patients. The risk of developing diabetic complications was analyzed using Kaplan–Meier analysis and the Cox proportional hazards model. By cluster analysis, we identified five distinct subgroups of adult-onset diabetes in the Japanese population. The risk of diabetic complications varied greatly among the clusters. Patients with severe autoimmune diabetes or severe insulin deficiency diabetes were at an increased risk of diabetic retinopathy, and those with severe insulin resistant diabetes (SIRD) had the highest risk of developing diabetic kidney disease (DKD). After adjusting for uncorrectable and correctable risk factors, SIRD was found to be an independent risk factor for DKD. In conclusion, we identified five subgroups of adult-onset diabetes and the risk factors for diabetic complications in the Japanese population. This new classification system can be effective in predicting the risk of diabetic complications and for providing optimal treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm9072083

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 31

  1. Udler, 2019, Type 2 Diabetes: Multiple Genes, Multiple Diseases, Curr. Diab. Rep., 19, 55, 10.1007/s11892-019-1169-7 · DOI · Paper page
  2. Pearson, 2019, Type 2 diabetes: A multifaceted disease, Diabetologia, 62, 1107, 10.1007/s00125-019-4909-y · DOI · Paper page
  3. Li, 2015, Identification of type 2 diabetes subgroups through topological analysis of patient similarity, Sci. Transl. Med., 7, 311ra174, 10.1126/scitranslmed.aaa9364 · DOI · Paper page
  4. Schwartz, 2016, The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema, Diabetes Care, 39, 179, 10.2337/dc15-1585 · DOI · Paper page
  5. Bancks, 2019, Epidemiology of diabetes phenotypes and prevalent cardiovascular risk factors and diabetes complications in the National Health and Nutrition Examination Survey 2003-2014, Diabetes Res. Clin. Pract., 158, 107915, 10.1016/j.diabres.2019.107915 · DOI · Paper page
  6. Thorens, 2019, Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion—A step towards precision medicine, Mol. Metab., 27, 147, 10.1016/j.molmet.2019.06.008 · DOI
  7. Zou, 2019, Novel subgroups of patients with adult-onset diabetes in Chinese and US populations, Lancet Diabetes Endocrinol., 7, 9, 10.1016/S2213-8587(18)30316-4 · DOI · Paper page
  8. Safai, 2018, Stratification of type 2 diabetes based on routine clinical markers, Diabetes Res. Clin. Pract., 141, 275, 10.1016/j.diabres.2018.05.014 · DOI
  9. Pedersen, 2014, Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Caucasians, Diabetes Care, 37, 796, 10.2337/dc13-0598 · DOI · Paper page
  10. Ahuja, 2015, Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: The ERA JUMP study, Diabetologia, 58, 265, 10.1007/s00125-014-3414-6 · DOI
  11. Ikezaki, 2016, Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring Study, Sci. Rep., 6, 36725, 10.1038/srep36725 · DOI
  12. Nakajima, A., Tanaka, K., Saito, H., Iwasaki, T., Oda, A., Kanno, M., Shimabukuro, M., Asahi, K., Watanabe, T., and Kazama, J.J. (2019). Blood pressure control in chronic kidney disease according to underlying renal disease: The Fukushima CKD cohort. Clin. Exp. Nephrol. · DOI
  13. Levy, 1998, Correct homeostasis model assessment (HOMA) evaluation uses the computer program, Diabetes Care, 21, 2191, 10.2337/diacare.21.12.2191 · DOI · Paper page
  14. Matsuo, 2009, Revised equations for estimated GFR from serum creatinine in Japan, Am. J. Kidney Dis., 53, 982, 10.1053/j.ajkd.2008.12.034 · DOI · Paper page
  15. Yasuda, 2007, Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy, Diabetes Res. Clin. Pract., 77, S178, 10.1016/j.diabres.2007.01.053 · DOI · Paper page
  16. Arai, 2018, Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017, J. Atheroscler. Thromb., 25, 751, 10.5551/jat.CR003 · DOI · Paper page
  17. Lee, 2010, Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease, Dig. Liver Dis., 42, 503, 10.1016/j.dld.2009.08.002 · DOI · Paper page
  18. Dennis, 2019, Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: An analysis using clinical trial data, Lancet Diabetes Endocrinol., 7, 442, 10.1016/S2213-8587(19)30087-7 · DOI · Paper page
  19. Yabe, 2015, β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians, Curr. Diab. Rep., 15, 602, 10.1007/s11892-015-0602-9 · DOI · Paper page
  20. Radcliffe, 2017, Clinical predictive factors in diabetic kidney disease progression, J. Diabetes Investig., 8, 6, 10.1111/jdi.12533 · DOI · Paper page
  21. Horita, 2016, Selective Insulin Resistance in the Kidney, BioMed. Res. Int., 2016, 5825170, 10.1155/2016/5825170 · DOI
  22. Karalliedde, 2016, Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease, Nephrol. Dial. Transpl., 31, 206
  23. Tariq, 2020, Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review, J. Clin. Exp. Hepatol., 10, 81, 10.1016/j.jceh.2019.07.008 · DOI
  24. Musso, 2016, Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities, Diabetes Care, 39, 1830, 10.2337/dc15-1182 · DOI · Paper page
  25. Chagnac, 2016, Obesity-related glomerulopathy: Clinical and pathologic characteristics and pathogenesis, Nat. Rev. Nephrol., 12, 453, 10.1038/nrneph.2016.75 · DOI · Paper page
  26. LeCaire, 2013, Assessing Progress in Retinopathy Outcomes in Type 1 Diabetes, Diabetes Care, 36, 631, 10.2337/dc12-0863 · DOI · Paper page
  27. Malone, 2001, Prevalence and Significance of Retinopathy in Subjects with Type 1 Diabetes of Less Than 5 Years’ Duration Screened for the Diabetes Control and Complications Trial, Diabetes Care, 24, 522, 10.2337/diacare.24.3.522 · DOI · Paper page
  28. Reaven, 1988, Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diab.37.12.1595 · DOI · Paper page
  29. Shimabukuro, 2009, Cardiac adiposity and global cardiometabolic risk: New concept and clinical implication, Circ. J., 73, 27, 10.1253/circj.CJ-08-1012 · DOI · Paper page
  30. Roden, 2019, The integrative biology of type 2 diabetes, Nature, 576, 51, 10.1038/s41586-019-1797-8 · DOI · Paper page
  31. Shimabukuro, 2016, Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men, Cardiovasc. Diabetol., 15, 77, 10.1186/s12933-016-0394-5 · DOI

Cited by

See all 112

Metadata

Authors
Tanabe, H., Saito, H., Kudo, A., Machii, N., Hirai, H., Maimaituxun, G., Tanaka, K., Masuzaki, H., Watanabe, T., Asahi, K., Kazama, J., & Shimabukuro, M.
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2020-07-02
Volume
9
Issue
7
Pages
2083
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3040193086
Cited by
112
References
8
FWCI
8.76
Type
journal article
Language
en
Open access
gold
Funders
  • Japan Society for the Promotion of Science (16K01823, 18K02242, 17K00924)
  • Japan Agency for Medical Research and Development (965304)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study. https://app.cochat.ai/papers/10.3390/jcm9072083
The paper
Tanabe, H., Saito, H., Kudo, A., Machii, N., Hirai, H., Maimaituxun, G., Tanaka, K., Masuzaki, H., Watanabe, T., Asahi, K., Kazama, J., & Shimabukuro, M. (2020). Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study. Journal of Clinical Medicine. https://doi.org/10.3390/jcm9072083

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.